DNA repair pathways in cancer therapy and resistance

L Li, Y Guan, X Chen, J Yang, Y Cheng - Frontiers in pharmacology, 2021 - frontiersin.org
DNA repair pathways are triggered to maintain genetic stability and integrity when
mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The …

Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology

MA Tempero, MP Malafa, M Al-Hawary… - Journal of the National …, 2021 - jnccn.org
Pancreatic cancer is the fourth leading cause of cancer-related death among men and
women in the United States. A major challenge in treatment remains patients' advanced …

[HTML][HTML] Curing pancreatic cancer

B Traub, KH Link, M Kornmann - Seminars in cancer biology, 2021 - Elsevier
The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer

N Tomita, H Ishida, K Tanakaya, T Yamaguchi… - International Journal of …, 2021 - Springer
Hereditary colorectal cancer (HCRC) accounts for< 5% of all colorectal cancer cases. Some
of the unique characteristics commonly encountered in HCRC cases include early age of …

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international …

EK Bancroft, EC Page, MN Brook, S Thomas… - The Lancet …, 2021 - thelancet.com
Background Lynch syndrome is a rare familial cancer syndrome caused by pathogenic
variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause …

Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers

P Georgeson, BJ Pope, C Rosty, M Clendenning… - Gut, 2021 - gut.bmj.com
Objective Germline pathogenic variants (PVs) in the DNA mismatch repair (MMR) genes and
in the base excision repair gene MUTYH underlie hereditary colorectal cancer (CRC) and …

Therapeutic strategies targeting tumor suppressor genes in pancreatic cancer

KK Kuo, PJ Hsiao, WT Chang, SC Chuang, YH Yang… - Cancers, 2021 - mdpi.com
Simple Summary Tumor suppressor genes are critical in the control of many biological
functions. They can be classified based on their roles in proliferation, cell-cycle progression …

[HTML][HTML] Germline and tumor sequencing as a diagnostic tool to resolve suspected Lynch syndrome

BJ Pope, M Clendenning, C Rosty, K Mahmood… - The Journal of Molecular …, 2021 - Elsevier
Patients in whom mismatch repair (MMR)-deficient cancer develops in the absence of
pathogenic variants of germline MMR genes or somatic hypermethylation of the MLH1 gene …

Clinical contribution of next-generation sequencing multigene panel testing for BRCA negative high-risk patients with breast cancer

AE Solmaz, L Yeniay, E Gökmen, O Zekioğlu… - Clinical Breast …, 2021 - Elsevier
Background Breast cancer is the most common malignancy in women and thought to be
hereditary in 10% of patients. Recent next-generation sequencing studies have increased …

Stakeholders' views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology

R O'Shea, NM Rankin, M Kentwell, M Gleeson… - European Journal of …, 2021 - nature.com
Mainstream genetic testing in routine oncology care requires implementation research to
inform intervention design. In Australia, funding is available for oncology health …